frince

About Frédéric Rince

This author has not yet filled in any details.
So far Frédéric Rince has created 543 blog entries.

Retrospective Analysis of Two EORTC Studies Showed That Gastric Acid Suppressants May Negatively Impact Survival Outcomes in Sarcoma Patients Treated With Pazopanib

Results from EORTC phase II 62043 and phase III 62072 [...]

By |2019-02-25T07:44:38+01:0025 Feb 2019|, |Comments Off on Retrospective Analysis of Two EORTC Studies Showed That Gastric Acid Suppressants May Negatively Impact Survival Outcomes in Sarcoma Patients Treated With Pazopanib
Read More

The initiative of EORTC staff members to help parents of children with cancer or stem cell therapies

In 2018, three members of EORTC staff, Liv Meert, Yuliya [...]

By |2019-01-29T16:10:35+01:0029 Jan 2019||Comments Off on The initiative of EORTC staff members to help parents of children with cancer or stem cell therapies
Read More

EORTC joins Horizon 2020 consortium to develop patient-centred health technology assessments

EORTC is a partner in the newly-launched HTx Project Consortium, [...]

By |2019-01-30T09:49:55+01:0029 Jan 2019||Comments Off on EORTC joins Horizon 2020 consortium to develop patient-centred health technology assessments
Read More

New trial in Glioblastoma – step forward in the battle against an aggressive and incurable disease

Glioblastoma is a fast-growing malignant brain tumour that develops from [...]

By |2018-12-13T08:56:05+01:0013 Dec 2018|, |Comments Off on New trial in Glioblastoma – step forward in the battle against an aggressive and incurable disease
Read More

Major EORTC trial presented at San Antonio Breast Cancer Symposium: 10-year follow-up of AMAROS shows benefits for post-operative radiotherapy to the axilla in patients with a tumour-positive sentinel node

Results from a 10-year follow of patients in the EORTC [...]

By |2019-01-29T10:00:39+01:007 Dec 2018|, |Comments Off on Major EORTC trial presented at San Antonio Breast Cancer Symposium: 10-year follow-up of AMAROS shows benefits for post-operative radiotherapy to the axilla in patients with a tumour-positive sentinel node
Read More

The EORTC Brain Tumor Group and Protagen AG announce their collaboration to investigate the immuno-competence of long-term Glioblastoma survivors

Zurich, Switzerland and Dortmund, Germany – 4 December 2018 – [...]

By |2018-12-04T14:09:12+01:004 Dec 2018|, |Comments Off on The EORTC Brain Tumor Group and Protagen AG announce their collaboration to investigate the immuno-competence of long-term Glioblastoma survivors
Read More
Go to Top